| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Aurora kinase A (AURKA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403678 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418569 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429157 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404924 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 4 from ORIGENE TECHNOLOGIES | LY404925 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 5 from ORIGENE TECHNOLOGIES | LY404926 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 5 from ORIGENE TECHNOLOGIES | LY430741 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 6 from ORIGENE TECHNOLOGIES | LY404927 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A (AURKA), transcript variant 6 from ORIGENE TECHNOLOGIES | LY430742 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A interacting protein 1 (AURKAIP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413482 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A interacting protein 1 (AURKAIP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426728 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase A interacting protein 1 (AURKAIP1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426729 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase B (AURKB) from ORIGENE TECHNOLOGIES | LY418144 | 100 ug | ORIGENE TECHNOLOGIES |
| Aurora kinase C (AURKC), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423127 | 100 ug | ORIGENE TECHNOLOGIES |
| Autism susceptibility candidate 2 (AUTS2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414435 | 100 ug | ORIGENE TECHNOLOGIES |
| Autism susceptibility candidate 2 (AUTS2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426730 | 100 ug | ORIGENE TECHNOLOGIES |
| Autism susceptibility candidate 2 (AUTS2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426731 | 100 ug | ORIGENE TECHNOLOGIES |
| Autocrine motility factor receptor (AMFR) from ORIGENE TECHNOLOGIES | LY420107 | 100 ug | ORIGENE TECHNOLOGIES |
| Autoimmune regulator (AIRE), transcript variant AIRE-1 from ORIGENE TECHNOLOGIES | LY424752 | 100 ug | ORIGENE TECHNOLOGIES |
| Autoimmune regulator (AIRE), transcript variant AIRE-2 from ORIGENE TECHNOLOGIES | LY424585 | 100 ug | ORIGENE TECHNOLOGIES |
| Autophagy/beclin-1 regulator 1 (AMBRA1) from ORIGENE TECHNOLOGIES | LY413575 | 100 ug | ORIGENE TECHNOLOGIES |
| AUTS2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418943 | 1 kit | ORIGENE TECHNOLOGIES |
| Auts2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501874 | 1 kit | ORIGENE TECHNOLOGIES |
| AVEN - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403707 | 1 kit | ORIGENE TECHNOLOGIES |
| Aven - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501876 | 1 kit | ORIGENE TECHNOLOGIES |
| AVEN Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303707 | 10 ug | ORIGENE TECHNOLOGIES |
| AVIL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412587 | 1 kit | ORIGENE TECHNOLOGIES |
| Cerkl - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503180 | 1 kit | ORIGENE TECHNOLOGIES |
| Avil - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501877 | 1 kit | ORIGENE TECHNOLOGIES |
| CERKL Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH323592 | 10 ug | ORIGENE TECHNOLOGIES |
| CER1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410111 | 1 kit | ORIGENE TECHNOLOGIES |
| Cer1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503177 | 1 kit | ORIGENE TECHNOLOGIES |
| Ceroid-lipofuscinosis, neuronal 5 (CLN5) from ORIGENE TECHNOLOGIES | LY416612 | 100 ug | ORIGENE TECHNOLOGIES |
| Ceroid-lipofuscinosis, neuronal 3 (CLN3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400027 | 100 ug | ORIGENE TECHNOLOGIES |
| Ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) from ORIGENE TECHNOLOGIES | LY412865 | 100 ug | ORIGENE TECHNOLOGIES |
| Ceroid-lipofuscinosis, neuronal 6, late infantile, variant (CLN6) from ORIGENE TECHNOLOGIES | LY402624 | 100 ug | ORIGENE TECHNOLOGIES |
| CERS2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200145 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200145BN | 1 kit | ORIGENE TECHNOLOGIES |
| CERS2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200145LP | 1 kit | ORIGENE TECHNOLOGIES |
| CERS2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200145RB | 1 kit | ORIGENE TECHNOLOGIES |
| CERS5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207649 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207649BN | 1 kit | ORIGENE TECHNOLOGIES |
| CERS5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207649LP | 1 kit | ORIGENE TECHNOLOGIES |
| CERS5 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207649RB | 1 kit | ORIGENE TECHNOLOGIES |
| CERS2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400145 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403402 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405167 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405511 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407649 | 1 kit | ORIGENE TECHNOLOGIES |
| CERS6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419555 | 1 kit | ORIGENE TECHNOLOGIES |